Stricter Drug Marketing Rules for Singapore

In January 2007, the revised International Code of Pharmaceutical Marketing Practices developed by the International Federation of Pharmaceutical Manufacturers & Association (IFPMA) became effective. Though the Singapore Association of Pharmaceutical Industries (SAPI) is part of the IFPMA, it has only recently stated... Read More


Orphan Drugs in Asia

While orphan drug laws in Asia may provide benefits for companies registering new drugs, such as marketing exclusivity, an expedited registration process, and a reduction in the number of clinical trials required, each registration process is unique and can pose a variety... Read More


Cancer in China

In recent years, cancer has become a more salient issue in China. Currently, 1.5 million Chinese die of cancer annually, more than any other disease, and this number is growing fast. Chinese make up one quarter of all cancer sufferers in the... Read More